{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:27:29Z","timestamp":1780118849649,"version":"3.54.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"\u201cLady Fairfax Foundation\u201d Sydney, Australia"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.bbrc.2010.06.019","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T04:44:56Z","timestamp":1276145096000},"page":"729-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis"],"prefix":"10.1016","volume":"397","author":[{"given":"Mohammad H.","family":"Pourgholami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levon M.","family":"Khachigian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger G.","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samina","family":"Badar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Wai Ling","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Lawson","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2010.06.019_bib1","first-page":"702","volume":"32","author":"Theodorides","year":"1976","journal-title":"Anthelmintic activity of albendazole against liver flukes, tapeworms, lung and gastrointestinal roundworms"},{"key":"10.1016\/j.bbrc.2010.06.019_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00001432-200212000-00008","article-title":"Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations","volume":"15","author":"Horton","year":"2002","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.bbrc.2010.06.019_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/004947559702700213","article-title":"The management of hydatid disease of the liver: Part 2","volume":"27","author":"Fenton-Lee","year":"1997","journal-title":"Trop. Doct."},{"key":"10.1016\/j.bbrc.2010.06.019_bib4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2460\/ajvr.1975.36.08.1153","article-title":"Influence of the anthelmintic mebendazole on microtubules and intracellular organelle movement in nematode intestinal cells","volume":"36","author":"Borgers","year":"1975","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.bbrc.2010.06.019_bib5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0006-2952(85)90611-2","article-title":"Structure-activity relationships of benzimidazole carbamates as inhibitors of mammalian tubulin","volume":"34","author":"Lacey","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2010.06.019_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0304-3835(01)00382-2","article-title":"In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole","volume":"165","author":"Pourgholami","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2010.06.019_bib7","first-page":"2963","article-title":"Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo","volume":"8","author":"Mukhopadhyay","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2010.06.019_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bcp.2007.05.006","article-title":"Epothilone-paclitaxel resistant leukemic cells CEM\/dEpoB300 are sensitive to albendazole: involvement of apoptotic pathways","volume":"74","author":"Khalilzadeh","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2010.06.019_bib9","first-page":"1201","article-title":"The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells","volume":"1","author":"Sasaki","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2010.06.019_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00280-004-0927-6","article-title":"Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis","volume":"55","author":"Pourgholami","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2010.06.019_bib11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00280-007-0538-0","article-title":"Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice","volume":"61","author":"Martarelli","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2010.06.019_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/07357900802210752","article-title":"Morris, inhibition of cell proliferation, vascular endothelial growth factor and tumor growth by albendazole","volume":"27","author":"Pourgholami","year":"2009","journal-title":"Cancer Invest."},{"key":"10.1016\/j.bbrc.2010.06.019_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-2407-10-143","article-title":"Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole","volume":"10","author":"Pourgholami","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2010.06.019_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/sonc.2002.37264","article-title":"Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications","volume":"29","author":"Ferrara","year":"2002","journal-title":"Semin. Oncol."},{"issue":"Suppl. 3","key":"10.1016\/j.bbrc.2010.06.019_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000088478","article-title":"VEGF as a key mediator of angiogenesis in cancer","volume":"69","author":"Carmeliet","year":"2005","journal-title":"Oncology"},{"key":"10.1016\/j.bbrc.2010.06.019_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2353\/ajpath.2006.050435","article-title":"EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown","volume":"168","author":"Ojima","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2010.06.019_bib17","doi-asserted-by":"crossref","first-page":"C947","DOI":"10.1152\/ajpcell.00389.2001","article-title":"Mechanisms of normal and tumor-derived angiogenesis","volume":"282","author":"Papetti","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrc.2010.06.019_bib18","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/sj.bjp.0707637","article-title":"Endothelial alpha1-adrenoceptors regulate neo-angiogenesis","volume":"153","author":"Ciccarelli","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2010.06.019_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1537-1891(03)00011-9","article-title":"Regulation of vascular permeability by vascular endothelial growth factors","volume":"39","author":"Bates","year":"2002","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.bbrc.2010.06.019_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/labinvest.2008.106","article-title":"Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling","volume":"89","author":"Awasthi","year":"2009","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2010.06.019_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbrc.2010.06.019_bib22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbrc.2006.09.049","article-title":"Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis","volume":"350","author":"Rajesh","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2010.06.019_bib23","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.bbrc.2006.09.160","article-title":"Poly(ADP-ribose)polymerase inhibition decreases angiogenesis","volume":"350","author":"Rajesh","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2010.06.019_bib24","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/nm1307","article-title":"Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo","volume":"11","author":"Chen","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2010.06.019_bib25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nbt1225","article-title":"Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun","volume":"24","author":"Fahmy","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2010.06.019_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/mvre.2001.2338","article-title":"Duran, VEGF increases permeability of the endothelial cell monolayer by activation of PKB\/akt, endothelial nitric-oxide synthase, and MAP kinase pathways","volume":"62","author":"Lal","year":"2001","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.bbrc.2010.06.019_bib27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbrc.2005.05.132","article-title":"Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy","volume":"333","author":"Ferrara","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2010.06.019_bib28","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1038\/sj.onc.1203855","article-title":"Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis","volume":"19","author":"Karkkainen","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2010.06.019_bib29","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2010.06.019_bib30","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nature04482","article-title":"Retinal angiogenesis in development and disease","volume":"438","author":"Gariano","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2010.06.019_bib31","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1158\/1078-0432.CCR-05-1181","article-title":"Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice","volume":"12","author":"Pourgholami","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2010.06.019_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10456-008-9099-z","article-title":"Vascular permeability, vascular hyperpermeability and angiogenesis","volume":"11","author":"Nagy","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bbrc.2010.06.019_bib33","first-page":"722","article-title":"Centrosomes, microtubules, and microfilaments in the reendothelialization and remodeling of double-sided in vitro wounds","volume":"66","author":"Ettenson","year":"1992","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2010.06.019_bib34","first-page":"1843","article-title":"The microtubule-affecting drug paclitaxel has antiangiogenic activity","volume":"2","author":"Belotti","year":"1996","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2010.06.019_bib35","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1182\/blood.V94.12.4143","article-title":"Antiangiogenesis is produced by nontoxic doses of vinblastine","volume":"94","author":"Vacca","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2010.06.019_bib36","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(93)90573-9","article-title":"High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis","volume":"72","author":"Millauer","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2010.06.019_bib37","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1038\/jid.2008.37","article-title":"Microtubule-targeted drugs inhibit VEGF receptor-2 expression by both transcriptional and post-transcriptional mechanisms","volume":"128","author":"Meissner","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbrc.2010.06.019_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/cgt.2010.7","article-title":"Antisense HIF-1alpha prevents acquired tumor resistance to angiostatin gene therapy","author":"Sun","year":"2010","journal-title":"Cancer Gene Ther."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X10011228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X10011228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:21:56Z","timestamp":1762093316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X10011228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0006291X10011228"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2010.06.019","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2010.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}